COVID-19 & CancerFreeGuest Editorial The COVID challenge: Maintaining progress in multiple myeloma clinical investigation July 31, 2020Vol.46 No.31By Hearn Jay Cho
COVID-19 & CancerFreeGuest Editorial To expedite progress against COVID-19, a public-private “accelerator” taps into real-world data June 26, 2020Vol.46 No.26By Jeff Allen and Susan C. Winckler
COVID-19 & CancerFreeGuest Editorial Conquest of COVID-19: Publish it to death? June 19, 2020Vol.46 No.25By Robert Peter Gale
COVID-19 & CancerFreeGuest Editorial Impact of COVID-19 on Georgia’s community providers: a snapshot from Georgia NCORP June 12, 2020Vol.46 No.24By Guilherme Cantuaria
COVID-19 & CancerFreeGuest Editorial Working to end cancer in the time of COVID-19 June 12, 2020Vol.46 No.24By Peter WT Pisters
COVID-19 & CancerFreeGuest Editorial ASCO data will provide actionable insights from the COVID-19 pandemic—for every patient June 05, 2020Vol.46 No.23By Richard L. Schilsky
FreeGuest Editorial Fostering a culture of gender-based respect and inclusion in oncology June 05, 2020Vol.46 No.23By Narjust Florez, Christina Chapman, Stephanie L. Graff, Tatiana M. Prowell and Miriam A. Knoll
FreeGuest Editorial I could have been George Floyd—many timesReflecting on the cancer of racism June 05, 2020Vol.46 No.23By Robert A. Winn
COVID-19 & CancerFreeGuest Editorial CCC19 data point to extensive use of hydroxychloroquine, azithromycin, or both, by patients with cancer and COVID-19 May 29, 2020Vol.46 No.22By Otis W. Brawley
